JPS621399B2 - - Google Patents
Info
- Publication number
- JPS621399B2 JPS621399B2 JP15292279A JP15292279A JPS621399B2 JP S621399 B2 JPS621399 B2 JP S621399B2 JP 15292279 A JP15292279 A JP 15292279A JP 15292279 A JP15292279 A JP 15292279A JP S621399 B2 JPS621399 B2 JP S621399B2
- Authority
- JP
- Japan
- Prior art keywords
- fluorouridine
- isopropylidene
- proton
- mmol
- chloroform
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- FHIDNBAQOFJWCA-UAKXSSHOSA-N 5-fluorouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(F)=C1 FHIDNBAQOFJWCA-UAKXSSHOSA-N 0.000 claims description 17
- 238000005886 esterification reaction Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 54
- -1 phenylacetyl Chemical group 0.000 description 42
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 30
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 27
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 26
- 239000000243 solution Substances 0.000 description 24
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 23
- 239000002904 solvent Substances 0.000 description 21
- 238000006243 chemical reaction Methods 0.000 description 19
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 14
- 238000004458 analytical method Methods 0.000 description 14
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 13
- 239000000203 mixture Substances 0.000 description 13
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 239000007864 aqueous solution Substances 0.000 description 12
- 238000000921 elemental analysis Methods 0.000 description 12
- 150000002148 esters Chemical class 0.000 description 11
- 239000011541 reaction mixture Substances 0.000 description 11
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 10
- LHTMLCXJMYPWGR-NPDIDSPYSA-N 5-fluoro-1-[(4r,6r)-6-(hydroxymethyl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-4-yl]pyrimidine-2,4-dione Chemical compound N1([C@@H]2O[C@H](CO)C3OC(OC32)(C)C)C=C(F)C(=O)NC1=O LHTMLCXJMYPWGR-NPDIDSPYSA-N 0.000 description 10
- 235000013736 caramel Nutrition 0.000 description 10
- 238000010898 silica gel chromatography Methods 0.000 description 10
- 239000000126 substance Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 238000005481 NMR spectroscopy Methods 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 150000001408 amides Chemical group 0.000 description 5
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 5
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- 239000012044 organic layer Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 239000000741 silica gel Substances 0.000 description 5
- 229910002027 silica gel Inorganic materials 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- XWKFPIODWVPXLX-UHFFFAOYSA-N 2-methyl-5-methylpyridine Natural products CC1=CC=C(C)N=C1 XWKFPIODWVPXLX-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 125000001118 alkylidene group Chemical group 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- MVGLBXWFOSHCCP-UHFFFAOYSA-N chloroform;tetrachloromethane Chemical compound ClC(Cl)Cl.ClC(Cl)(Cl)Cl MVGLBXWFOSHCCP-UHFFFAOYSA-N 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 238000004949 mass spectrometry Methods 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- 125000000066 S-methyl group Chemical group [H]C([H])([H])S* 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000009876 antimalignant effect Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 3
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M sodium bicarbonate Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- OEAFZNRGZZNREY-SEFVSHJNSA-N 1-o-benzyl 2-o-[[(2r,3s,4r,5r)-5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl] (2s)-pyrrolidine-1,2-dicarboxylate Chemical compound C([C@H]1C(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C(NC(=O)C(F)=C2)=O)CCN1C(=O)OCC1=CC=CC=C1 OEAFZNRGZZNREY-SEFVSHJNSA-N 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- HRBGUGQWTMBDTR-UHFFFAOYSA-N 2,3,4-tri(propan-2-yl)benzenesulfonyl chloride Chemical compound CC(C)C1=CC=C(S(Cl)(=O)=O)C(C(C)C)=C1C(C)C HRBGUGQWTMBDTR-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
- ZCXMFBUYRUWFAQ-PBEGBBSFSA-N [(2r,3s,4r,5r)-5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl (2s)-2-(butanoylamino)-3-methylbutanoate Chemical compound O[C@@H]1[C@H](O)[C@@H](COC(=O)[C@H](C(C)C)NC(=O)CCC)O[C@H]1N1C(=O)NC(=O)C(F)=C1 ZCXMFBUYRUWFAQ-PBEGBBSFSA-N 0.000 description 2
- FKEFWONOONUTEI-FSNPWBFUSA-N [(2r,3s,4r,5r)-5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl (2s)-3-methyl-2-(phenylmethoxycarbonylamino)butanoate Chemical compound N([C@@H](C(C)C)C(=O)OC[C@@H]1[C@H]([C@@H](O)[C@@H](O1)N1C(NC(=O)C(F)=C1)=O)O)C(=O)OCC1=CC=CC=C1 FKEFWONOONUTEI-FSNPWBFUSA-N 0.000 description 2
- GLPMXIIHERHMQE-QBRBXANFSA-N [(2r,3s,4r,5r)-5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl (2s)-3-phenyl-2-(phenylmethoxycarbonylamino)propanoate Chemical compound C([C@@H](C(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C(NC(=O)C(F)=C1)=O)O)O)NC(=O)OCC=1C=CC=CC=1)C1=CC=CC=C1 GLPMXIIHERHMQE-QBRBXANFSA-N 0.000 description 2
- 125000004448 alkyl carbonyl group Chemical group 0.000 description 2
- 239000000010 aprotic solvent Substances 0.000 description 2
- AYJRCSIUFZENHW-UHFFFAOYSA-L barium carbonate Chemical compound [Ba+2].[O-]C([O-])=O AYJRCSIUFZENHW-UHFFFAOYSA-L 0.000 description 2
- 150000007514 bases Chemical class 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- AKPUJVVHYUHGKY-UHFFFAOYSA-N hydron;propan-2-ol;chloride Chemical compound Cl.CC(C)O AKPUJVVHYUHGKY-UHFFFAOYSA-N 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- 229960004441 tyrosine Drugs 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- QUCAHWMUAMQNFV-IBGZPJMESA-N (2S)-3-(4-hydroxyphenyl)-2-[pentanoyloxy(phenylmethoxycarbonyl)amino]propanoic acid Chemical compound C(CCCC)(=O)ON([C@@H](CC1=CC=C(C=C1)O)C(=O)O)C(=O)OCC1=CC=CC=C1 QUCAHWMUAMQNFV-IBGZPJMESA-N 0.000 description 1
- JXGVXCZADZNAMJ-NSHDSACASA-N (2s)-1-phenylmethoxycarbonylpyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@@H]1CCCN1C(=O)OCC1=CC=CC=C1 JXGVXCZADZNAMJ-NSHDSACASA-N 0.000 description 1
- PECAWSDTQIFOPF-ZDUSSCGKSA-N (2s)-2-(decanoylamino)-4-methylsulfanylbutanoic acid Chemical compound CCCCCCCCCC(=O)N[C@H](C(O)=O)CCSC PECAWSDTQIFOPF-ZDUSSCGKSA-N 0.000 description 1
- CGTHEWLEJCUUCV-IBGZPJMESA-N (2s)-2-(pentanoylamino)-3-(4-phenylmethoxycarbonyloxyphenyl)propanoic acid Chemical compound C1=CC(C[C@H](NC(=O)CCCC)C(O)=O)=CC=C1OC(=O)OCC1=CC=CC=C1 CGTHEWLEJCUUCV-IBGZPJMESA-N 0.000 description 1
- RRONHWAVOYADJL-HNNXBMFYSA-N (2s)-3-phenyl-2-(phenylmethoxycarbonylamino)propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)OCC=1C=CC=CC=1)C1=CC=CC=C1 RRONHWAVOYADJL-HNNXBMFYSA-N 0.000 description 1
- FPKHNNQXKZMOJJ-NSHDSACASA-N (2s)-4-methylsulfanyl-2-(phenylmethoxycarbonylamino)butanoic acid Chemical compound CSCC[C@@H](C(O)=O)NC(=O)OCC1=CC=CC=C1 FPKHNNQXKZMOJJ-NSHDSACASA-N 0.000 description 1
- UOCLXMDMGBRAIB-UHFFFAOYSA-N 1,1,1-trichloroethane Chemical compound CC(Cl)(Cl)Cl UOCLXMDMGBRAIB-UHFFFAOYSA-N 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- YRQCXKWIUIJBJN-YSSBGUOXSA-N 1-[(2r,3r,4s,5s)-3,4-dihydroxy-5-(1-hydroxy-2-methylprop-1-enyl)oxolan-2-yl]-5-fluoropyrimidine-2,4-dione Chemical compound O[C@@H]1[C@H](O)[C@@H](C(O)=C(C)C)O[C@H]1N1C(=O)NC(=O)C(F)=C1 YRQCXKWIUIJBJN-YSSBGUOXSA-N 0.000 description 1
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- FAIZHAKOWDWMMK-ZAPJKBGESA-N [(2R,3S,4R,5R)-5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl (2S)-3-hydroxy-2-(phenylmethoxycarbonylamino)propanoate Chemical compound C(C1=CC=CC=C1)OC(=O)N[C@@H](CO)C(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C(=O)NC(=O)C(=C1)F)O)O FAIZHAKOWDWMMK-ZAPJKBGESA-N 0.000 description 1
- AFOUITUOOKDECA-YWCCWUOUSA-N [(2r,3s,4r,5r)-5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl (2r)-3-benzylsulfanyl-2-(phenylmethoxycarbonylamino)propanoate Chemical compound C([C@@H](C(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C(NC(=O)C(F)=C1)=O)O)O)NC(=O)OCC=1C=CC=CC=1)SCC1=CC=CC=C1 AFOUITUOOKDECA-YWCCWUOUSA-N 0.000 description 1
- LZDZKYWQWUCFNC-PJDYVGSDSA-N [(2r,3s,4r,5r)-5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl (2s)-3-(4-hydroxyphenyl)-2-(pentanoylamino)propanoate Chemical compound C([C@H](NC(=O)CCCC)C(=O)OC[C@@H]1[C@H]([C@@H](O)[C@@H](O1)N1C(NC(=O)C(F)=C1)=O)O)C1=CC=C(O)C=C1 LZDZKYWQWUCFNC-PJDYVGSDSA-N 0.000 description 1
- XOLYMOAEPXAVGQ-PJDYVGSDSA-N [(2r,3s,4r,5r)-5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl (2s)-4-methylsulfanyl-2-(3-phenylpropanoylamino)butanoate Chemical compound N([C@@H](CCSC)C(=O)OC[C@@H]1[C@H]([C@@H](O)[C@@H](O1)N1C(NC(=O)C(F)=C1)=O)O)C(=O)CCC1=CC=CC=C1 XOLYMOAEPXAVGQ-PJDYVGSDSA-N 0.000 description 1
- DYADTGFGLFIFLN-LMWHNAIISA-N [(2r,3s,4r,5r)-5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl (2s)-4-methylsulfanyl-2-(pentanoylamino)butanoate Chemical compound O[C@@H]1[C@H](O)[C@@H](COC(=O)[C@H](CCSC)NC(=O)CCCC)O[C@H]1N1C(=O)NC(=O)C(F)=C1 DYADTGFGLFIFLN-LMWHNAIISA-N 0.000 description 1
- ZCGHCZMVDSJOFI-SEFVSHJNSA-N [(2r,3s,4r,5r)-5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl (2s)-4-methylsulfanyl-2-(phenylmethoxycarbonylamino)butanoate Chemical compound N([C@@H](CCSC)C(=O)OC[C@@H]1[C@H]([C@@H](O)[C@@H](O1)N1C(NC(=O)C(F)=C1)=O)O)C(=O)OCC1=CC=CC=C1 ZCGHCZMVDSJOFI-SEFVSHJNSA-N 0.000 description 1
- NYJHRXPVSDZAFU-DNNBLBMLSA-N [(2r,3s,4r,5r)-5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl 2-(phenylmethoxycarbonylamino)acetate Chemical compound C([C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C(NC(=O)C(F)=C1)=O)OC(=O)CNC(=O)OCC1=CC=CC=C1 NYJHRXPVSDZAFU-DNNBLBMLSA-N 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 150000001266 acyl halides Chemical class 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000001370 alpha-amino acid derivatives Chemical class 0.000 description 1
- 235000008206 alpha-amino acids Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 125000003435 aroyl group Chemical group 0.000 description 1
- 125000005098 aryl alkoxy carbonyl group Chemical group 0.000 description 1
- 125000005099 aryl alkyl carbonyl group Chemical group 0.000 description 1
- 239000003637 basic solution Substances 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 1
- 125000000649 benzylidene group Chemical group [H]C(=[*])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- DVECBJCOGJRVPX-UHFFFAOYSA-N butyryl chloride Chemical compound CCCC(Cl)=O DVECBJCOGJRVPX-UHFFFAOYSA-N 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- HRYZWHHZPQKTII-UHFFFAOYSA-N chloroethane Chemical compound CCCl HRYZWHHZPQKTII-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- HPYNZHMRTTWQTB-UHFFFAOYSA-N dimethylpyridine Natural products CC1=CC=CN=C1C HPYNZHMRTTWQTB-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- YWGHUJQYGPDNKT-UHFFFAOYSA-N hexanoyl chloride Chemical compound CCCCCC(Cl)=O YWGHUJQYGPDNKT-UHFFFAOYSA-N 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 125000000654 isopropylidene group Chemical group C(C)(C)=* 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229960004452 methionine Drugs 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- XGISHOFUAFNYQF-UHFFFAOYSA-N pentanoyl chloride Chemical compound CCCCC(Cl)=O XGISHOFUAFNYQF-UHFFFAOYSA-N 0.000 description 1
- 229960005190 phenylalanine Drugs 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 229960002429 proline Drugs 0.000 description 1
- RZWZRACFZGVKFM-UHFFFAOYSA-N propanoyl chloride Chemical compound CCC(Cl)=O RZWZRACFZGVKFM-UHFFFAOYSA-N 0.000 description 1
- 239000003586 protic polar solvent Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 125000005270 trialkylamine group Chemical group 0.000 description 1
- 229960004799 tryptophan Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
- 229940045145 uridine Drugs 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Landscapes
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
本発明は一般式
(式中、AはN―アシル―α―アミノカルボオ
キシ基を表す)
で表わされる新規な5―フルオロウリジン―5′―
エステル誘導体及びその製造方法に関する。
本発明に係る5―フルオロウリジン誘導体はい
ずれも本発明者等によつて創製された新規物質で
あつて医薬、特に抗悪性腫瘍剤、抗ビールス剤、
免疫抑制剤として、又これらの中間体として有用
な化合物である。
本発明に係る5―フルオロウリジン誘導体の化
学構造の一部を構成するN―アシル―α―アミノ
カルボオキシ基は、相当するN―アシル―α―ア
ミノカルボン酸の化学構造に由来するものであ
る。ここでα―アミノカルボン酸とは天然もしく
は合成のアミノ酸をさすものであり、このα―ア
ミノ酸の例としてはグリシン、アラニン、バリ
ン、ロイシン、イソロイシン、セリン、スレオニ
ン、システイン、メチオニン、フエニルアラニ
ン、チロシン、トリプトフアン、プロリン、オキ
シプロリンがあげられる。
α―アミノカルボン酸のN原子に位置するアシ
ル基の例としてはエトキシカルボニル、ベンジル
オキシカルボニル等のアルキル又はアラルキルオ
キシカルボニル基;メチル、エチル、ブチル、ノ
ニル等の炭素数1〜10のアルキルカルボニル基;
ベンゾイル等のアロイル基;フエニルアセチル、
フエニルプロピオニル等のアラルキルカルボニル
基や2―(ベンゾイルチオ)プロピオニル等のベ
ンゾイルチオ低級アルキルカルボニル基等があげ
られる。
本発明に係るこれらの新規な5―フルオロウリ
ジン誘導体はいずれも優れた抗悪性腫瘍作用を有
する。この抗悪性腫瘍作用をCDF1系マウスで調
べた結果の例を本明細書末尾の表3に示す。
本発明に係る5―フルオロウリジン誘導体は、
優れた抗悪性腫瘍作用を有するとともに、且つ安
全係数(最高生命延長率用量/25%生命延長率用
量)が極めて大であり安全性の点においても優れ
ているものである。
本発明に係る5―フルオロウリジン誘導体はN
―アシル―α―アミノカルボン酸のカルボキシ基
と5―フルオロウリジンの5′位―OHとをエステ
ル結合反応により結合し、エステル化することに
より得られる。このエステル化の方法それ自体は
通常よく知られたエステル化法ならびにその変法
いずれでもよく特定されない。
出発原料の一つであるN―アシル―α―アミノ
カルボン酸は、本発明の目的に合致する適当なア
シルハライドとα―アミノカルボン酸とから常法
に従つて得られ、そのまゝの形か又はそのハライ
ドや無水物の様な反応性誘導体とした上で反応に
供せられる。
また、他の一方の出発原料である5―フルオロ
ウリジンは既知物質であり、通常は副反応を防止
する為にその2′位及び3′位の―OHを常法により
保護基によつて保護した形で反応に供するのが良
い。その際の保護基は特定されるものではなく、
例示すればイソプロピリデン、エトキシエチリデ
ン、ベンジリデン等のアルキリデン基である。
好ましい反応方法はN―アシル―α―アミノカ
ルボン酸と2′,3′―O―アルキリデン―5―フル
オロウリジンとをエステル結合させ、次いでアル
キリデン基を除去して目的化合物を得る方法であ
る。
この方法によつてN―アシル―α―アミノカル
ボン酸と2′,3′―O―アルキリデン―5―フルオ
ロウリジンとをエステル結合させるには、常法に
より例えば、両者を無水溶媒中で塩基性化合物と
縮合剤との存在下に40℃以下で反応させる。
この際溶媒としては無水の非プロトン性溶媒が
用いられるがその例としてはベンゼン、トルエ
ン、キシレン、ハロゲン化炭化水素例えばジクロ
ルメタン、クロロホルム、モノクロルエタン、ジ
クロルエタン、トリクロルエタン等、エーテル、
テトラヒドロフラン、ジオキサン、ピリジン、ニ
トロメタン等があげられる。
上記の塩基性化合物としてはトリアルキルアミ
ン、ピリジン、ピコリン、ルチジン等の3級アミ
ン又は炭酸水素ナトリウム、炭酸ナトリウム、炭
酸バリウム等の無機塩基を用いることが出来る
が、ピリジンを用いると溶媒を兼ねることも出来
るという利点がある。
縮合剤としてはp―トルエンスルフオニルクロ
リド、トリイソプロピルベンゼンスルフオニルク
ロリド、メタンスルフオニルクロリド等のアリー
ルスルフオニルクロリド又はアルキルスルフオニ
ルクロリドやジシクロヘキシルカーボジイミド、
チオニルクロリド、オキシ塩化燐等を用いること
が出来る。
反応における各物質の使用モル比は、通常は例
えば2′,3′―O―アルキリデン―5―フルオロウ
リジン1モルに対しN―アシル―α―アミノカル
ボン酸、塩基性化合物、縮合剤、各1〜3モル程
度である。
反応は40℃以下で行われ、通常、1〜44時間で
完結する。
この縮合反応の結果生ずる中間体は適当な方法
により分離した後アルキリデン基を除去して目的
とする化合物を得る。
アルキリデン基を除去する反応は常法により、
溶媒中で酸の存在下に40℃以下で行われる。この
際用いられる酸としては塩酸、硫酸等の鉱酸や酢
酸、トリフルオロ酢酸等の有機酸があげられ、溶
媒としてはプロトン性溶媒例えば水、メタノー
ル、エタノール、ぎ酸、酢酸等又はこれらの混合
物があげられる。場合によつては非プロトン性溶
媒を組合せて使用しても良い。反応時間は通常
は、30分〜20時間である。
生成する目的化合物はクロマト法等により精製
される。
次に製造に関する実施例を掲げる。
実施例 1
5′―O―(N―ベンジルオキシカルボニルメチ
オニル)―5―フルオロウリジン
N―ベンジルオキシカルボニル―L―メチオニ
ン940mg(3.3mmol)と、2′,3′―O―エトキシエ
チリデン―5―フルオロウリジン530mg
(1.7mmol)とを無水ピリジン5mlで3回共沸脱
水したのち、無水ピリジンに溶解しトリイソプロ
ピルベンゼンスルフオニルクロリド(以下TPSと
略記する)1.0g(3.3mmol)を加え、室温下20
時間撹拌し反応させた。溶媒を減圧で留去し残留
物をクロロホルム100mlと水100ml(この水層は固
体炭酸ナトリウムを用いてPH7.5〜8に保つた)
に分配し、クロロホルム層を無水硫酸ナトリウム
で乾燥し、ろ過した後クロロホルムを減圧で留去
した。残留物をクロロホルム3mlに溶解してシリ
カゲル20gに吸着させた後1%のメタノールを含
むクロロホルムで展開して5′―O―(N―ベンジ
ルオキシカルボニルメチオニル)―2′,3′―O―
エトキシエチリデン―5―フルオロウリジン970
mgを得た。〔核磁気共鳴スペクトル(DMSO―
d6)δppm11.46(bs、1H、H3)、8.08(d、
1H、H6)、7.30(s、5H、フエニルプロトン)、
5.7(bs、1H、H1′)、5.10(s、2H、O―ベンジ
ルメチレンプロトン)、3.6(bq、2H、C―メチ
レンプロトン)、2.6(s、3H、s―メチルプロ
トン)、1.2(m、3H、C―メチルプロトン)〕。
つづいてこのエステルをエタノール15mlにとか
し、90%ぎ酸水溶液3mlと水7mlを加えて室温で
20時間反応させた。反応液を減圧で留去した後残
留物をクロロホルム3mlに溶解してシリカゲル15
gに吸着させ、3%のメタノールを含むクロロホ
ルムで展開して目的の5′―O―N―ベンジルオキ
シカルボニルメチオニル―5―フルオロウリジン
790mgを無色のカラメルとして得た。
質量分析値:527(M+)、397、398、130
元素分析(C22H26N3O9FSとして)
C H N
分析値:49.85% 5.02% 7.94%
理論値:49.85% 5.02% 7.94%
実施例 2
5―O―(N―デカノイルメチオニル)―5―
フルオロウリジン
2′,3′―O―イソプロピリデン―5―フルオロ
ウリジン1.00g(3.30mmol)とN―デカノイル
メチオニン2.00g(6.60mmol)を無水ピリジン
7mlに溶解したのちTPS2.00g(6.60mmol)を
加え室温で44時間反応させた。溶媒を減圧で留去
後残留物をクロロホルム100mlと水100ml(この水
層は固体炭酸ナトリウムを用いてPH7.5〜8に保
つた)に分配し、クロロホルム層を無水硫酸ナト
リウムで乾燥しろ過した後クロロホルムを減圧で
留去した。
残留物をクロロホルム5mlに溶解してシリカゲ
ル150gに吸着させ、1%のメタノールを含むク
ロロホルムで展開した5′―O―(N―デカノイル
メチオニル)―2′,3′―O―イソプロピリデン―
5―フルオロウリジン1.17gを無色カラメルとし
て得た。〔核磁気共鳴スペクトル(CDCl3)δ
ppm、10.3(bs、1H、3H)、7.70(d、0.5H、
H6)、7.60(d、0.5H、H6)5.85(bs、0.5H、
H1′)、5.70(bs、0.5、H1′)、2.10(s、3H、メ
チルチオプロトン)、1.61、1.42(s,s、3H×
2、イソプロピリデンメチルプロトン)、1.25
(bs、14H、C―メチレンプロトン)、0.90(bt、
3H、C―メチルプロトン)〕。
つづいてこのエステル970mg(1.65mmol)を90
%トリフルオロ酢酸水溶液5mlに溶解し、室温下
に1時間撹拌反応させた。
反応液を減圧で留去し、残留物をクロロホルム
5mlに溶解してシリカゲル20gに吸着させたのち
3%のメタノールを含むクロロホルムで展開して
目的の5′―O―(N―デカノイルメチオニル)―
5―フルオロウリジン750mgを得た。m.p.133―
6℃(イソプロパノール)
質量分析:547(M+)、418、130、
元素分析(C24H38N3O8SFとして)
C H N
分析値:52.74% 6.85% 7.81%
理論値:52.64% 6.99% 7.67%
実施例 3
5′―O―{N―(3―フエニルプロピオニル)
メチオニル}―5―フルオロウリジン
N―(3―フエニルプロピオン)メチオニル
940mg(3.35mmol)と2′,3′―O―イソプロピリ
デン―5―フルオロウリジン600mg(1.99mmol)
を無水ピリジン20mlに溶かしたのち、TPS1.00g
(3.31mmol)を加え室温で4.5時間反応させた。
この反応混合物を実施例1及び2に準じて操作す
ると5′―O―{N―(3―フエニルプロピオニ
ル)メチオニル2′,3′―O―イソプロピリデン―
5―フルオロウリジン350mgが無色のカラメルと
して得られた。〔核磁気共鳴(CDCl3)δppm、
7.54(d、0.5H、H6)、7.44(d、0.5H、H6)、
7.21(s、5H、フエニルプロトン)、5.71(d、
0.5H、H1′)、5.58(d、0.5H、H1′)、2.03(s、
3H、チオメチルプロトン)、1.55、1.34(s,
s、3H×2、イソプロピリデンメチルプロト
ン)〕。
上記で得られたエステル440mg(1.20mmol)を
90%トリフルオロ酢酸水溶液2mlに溶かし、室温
で1時間反応させた。この反応混合物を実施例1
及び2に準じて処理すると、目的の5′―O―{N
―(3―フエニルプロピオニル)メチオニル}―
5―フルオロウリジン300mgが無色カラメルとし
て得られた。
質量分析:525(M+)、394、130、
元素分析(C23H28N3O8FSとして)
C H N
分析値:52.64% 5.56% 8.11%
理論値:52.56% 5.37% 8.00%
実施例 4
5′―O―(N―ペンタノイルメチオニル)―5
―フルオロウリジン
N―ペンタノイルメチオニン3.00g
(12.9mmol)と2′,3′―O―イソプロピリデンン
―5―フルオロウリジン1.94g(6.44mmol)を
無水ピリジンで共沸脱水したのち、無水ピリジン
40mlに溶かしTPS5.50g(18.2mmol)を加え室
温で25時間反応させた。この反応混合物を実施例
1及び2に準じて処理すると5′―O―(N―(ペ
ンタノイルメチオニル)―2′,3′―O―イソプロ
ピリデン―5―フルオロウリジン1.39gが無色カ
ラメルとして得られた。〔核磁気共鳴(CDCl3)δ
ppm、7.62(d、0.5H、H6)、7.42(d、0.5H、
H6)5.77(bd、0.5H、H1′)、5.62(bd、0.5H、
H1′)、2.07(s、3H、チオメチルプロトン)、
1.56、1.36(s,s、3H×2、イソプロピリデン
メチルプロトン)、0.90(bt、3H、C―メチレン
プロトン)〕。
上記で得られたエステル1.01g(1.95mmol)
をクロロホルム4mlに溶かし、90%トリフルオロ
酢酸水溶液20mlを加えて室温で1.5時間反応させ
た。この反応混合物を実施例1及び2に準じて処
理すると5′―O―(N―ペンタノイルメチオニ
ル)―5―フルオロウリジン840mgが無色カラメ
ルとして得られた。
質量分析:477(M+)、347、130、
元素分析(C19H28N3O8SFとして)
C H N
分析値:47.61% 5.97% 8.52%
理論値:47.79% 5.91% 8.80%
実施例 5
5′―O―(N―ベンジルオキシカルボニルプロ
リル)―5―フルオロウリジン
N―ベンジルオキシカルボニル―L―プロリン
3.30g(13.2mmol)、2′,3′―O―イソプロピリ
デン―5―フルオロウリジン2.00g(6.6mmol)
を無水ピリジン14mlに溶かし、ついでTPS4.00g
(13.2mmol)を加えて室温で3時間撹拌反応させ
た。この反応混合物を実施例1及び2に準じて処
理すると、5′―O―(N―ベンジルオキシカルボ
ニルプロリル)―2′,3′―O―イソプロピリデン
―5―フルオロウリジン3.00gが得られた。〔核
磁気共鳴スペクトル(CDCl3、TMS)、δppm、
10.0(bs、1H、H3)、7.35(bs、6H、フエニルプ
ロトン及びH6)、5.85(bs、0.5H、H1′)5.75
(bs、0.5H、H1′)、5.20(s、2H、ベンジルメチ
レンプロトン)、3.60(bt、2H、―N―メチレン
プロトン)2.1(m、4H、C―メチレンプロト
ン)、1.60(s、3H、イソプロピリデンメチルプ
ロトン)、1.40(s、3H、イソプロピリデンメチ
ルプロトン)〕。
続いて上記で得られたエステル3.06g
(5.74mmol)を90%トリフルオロ酢酸水溶液12ml
に溶かし、室温で1.5時間撹拌反応させた。この
反応混合物を実施例1及び2に準じて処理すると
5′―O―(N―ベンジルオキシカルボニルプロリ
ル)―5―フルオロウリジン1.63gが得られた。
融点 137〜144゜(イソプロパノール)
質量分析値:493(M+)、358、130、
元素分析(C22H24N3O9Fとして)
C H N
分析値:53.44% 4.89% 8.59%
理論値:53.55% 4.90% 8.52%
実施例 6
5′―O―(N―ベンジルオキシカルボニルバリ
ル)―5―フルオロウリジン
N―ベンジルオキシカルボニル―L―バリル
3.51g(13.98mmol)と、2′,3′―O―イソプロ
ピリデン―5―フルオロウリジン2.72g
(9.00mmol)を無水ピリジンで共沸脱水したのち
無水ピリジン50mlに溶かしTPS5.40g
(17.82mmol)を加えて室温で20時間反応させ
た。この反応混合物を実施例1及び2に準じて処
理すると、5′―O―(N―ベンジルオキシカルボ
ニルバリン)―2′,3′―O―イソプロピリデン―
5―フルオロウリジン3.62gが無色カラメルとし
て得られた。〔核磁気共鳴スペクトル(CDCl3、
TMS)、δppm、7.40(s及びd、6H、フエニル
プロトン及びH6)、5.63(d、1H、H1′)、5.18
(s、2H、ベンジルメチルプロトン)、5.0(m、
2H、H2′及びH3′)、4.4(bs、4H、H5′、H4′及び
N―メチンプロトン)、2.2(m、1H、C―メチ
ンプロトン)、1.58、1.46(s,s、3H×2、イ
ソプロピリデンメチルプロトン)、0.92(d,
d、6H、イソプロピルメチルプロトン)〕。
次いで上記で得られたエステル3.49gをクロロ
ホルム4mlに溶かし、90%トリフルオロ酢酸水溶
液10mlを加えて室温で3時間反応させた。この反
応混合物を実施例1及び2に準じて処理すると、
5′―O―(N―ベンジルオキシカルボニルバリ
ル)―5―フルオロウリジン2.11gが無色カラメ
ルとして得られた。
質量分析値:495(M+)、365、130
元素分析(C22H26N3O9F・H2Oとして)
C H N
分析値:51.56% 5.25% 7.82%
理論値:51.46% 5.50% 8.18%
実施例 7
5′―O―(N―ベンジルオキシカルボニルフエ
ニルアラニル)―5―フルオロウリジン
N―ベンジルオキシカルボニル―L―フエニル
アラニン3.00g(10.0mmol)と2′,3′―O―イソ
プロピリデン―5―フルオロウリジン1.50g
(5.00mmol)とを無水ピリジン40mlに溶かした後
TPS3.00g(10.0mmol)を加え室温で2時間撹
拌し反応させた。この反応混合物を次いで実施例
1及び2の方法に準じて処理すると5′―O―(N
―ベンジルオキシカルボニルフエニルアラニル)
―2′,3′―O―イソプロピリデン―5―フルオロ
ウリジン2.80gが無色カラメルとして得られた。
〔核磁気共鳴スペクトル(CDCL3、TMS)、δ
ppm、7.39及び7.3(s及びm、11H、フエニルプ
ロトン及びH6)、5.68(d、1H、H1′)、5.15
(s、2H、O―ベンジルメチレンプロトン)、
3.15(d、2H、C―ベンジルプロトン)、1.58、
1.37(s,s、3H×2、イソプロピリデンメチ
ルプロトン)〕。
得られたこのエステル1.20gを90%トリフルオ
ロ酢酸水溶液5mlに溶かし、室温で30分撹拌し反
応させた。この反応混合物を実施例1及び2に準
じて処理すると、5′―O―(N―ベンジルオキシ
カルボニルフエニルアラニル)―5―フルオロウ
リジン940mgが無色カラメルとして得られた。
質量分析値:543(M+)、414、130、
元素分析(C26H26N3O9Fとして)
C H N
分析値:57.34% 4.83% 8.00%
理論値:57.46% 4.82% 7.73%
実施例 8〜16
相当するN―アシル―α―アミノカルボン酸と
2′,3′―O―イソプロピリデン―5―フルオロウ
リジンとを用いて以下の化合物を得た。
5′―O―(N―フエニルアセチルメチオニル)
―5―フルオロウリジン、
5′―O―(N―ベンゾイルグリシル)―5―フ
ルオロウリジン、
5′―O―(N―デカノイルグリシル)―5―フ
ルオロウリジン、
5′―O―{N―(n―ペンタノイルグリシ
ル)}―5―フルオロウリジン、
5′―O―{N―(2―ベンゾイルチオプロピオ
ニル)グリシル}―5―フルオロウリジン、
5′―O―(N―ベンジルオキシカルボニル―S
―ベンジルシステイニル)5―フルオロウリジ
ン)
5′―O―(N―ベンジルオキシカルボニルグリ
シル)―5―フルオロウリジン、
5′―O―(N―ベンジルオキシカルボニルトリ
プトフアニル)―5―フルオロウリジン、
5′―O―(N―ベンジルオキシカルボニルセリ
ル)―5―フルオロウリジン、
実施例1〜16において得られた各5―フルオロ
ウリジン―5′―エステルの核磁気共鳴スペクトル
の化学シフト値を表1に表す。
The present invention is based on the general formula (In the formula, A represents an N-acyl-α-aminocarboxy group) A novel 5-fluorouridine-5′-
This invention relates to ester derivatives and methods for producing the same. The 5-fluorouridine derivatives according to the present invention are all new substances created by the present inventors, and are used as pharmaceuticals, especially anti-cancer agents, anti-viral agents, etc.
It is a compound useful as an immunosuppressant and as an intermediate thereof. The N-acyl-α-aminocarboxy group that constitutes a part of the chemical structure of the 5-fluorouridine derivative according to the present invention is derived from the chemical structure of the corresponding N-acyl-α-aminocarboxylic acid. . Here, α-aminocarboxylic acid refers to a natural or synthetic amino acid, and examples of this α-amino acid include glycine, alanine, valine, leucine, isoleucine, serine, threonine, cysteine, methionine, phenylalanine, Examples include tyrosine, tryptophan, proline, and oxyproline. Examples of acyl groups located at the N atom of α-aminocarboxylic acids include alkyl or aralkyloxycarbonyl groups such as ethoxycarbonyl and benzyloxycarbonyl; alkylcarbonyl groups having 1 to 10 carbon atoms such as methyl, ethyl, butyl, and nonyl. ;
Aroyl group such as benzoyl; phenylacetyl,
Examples include aralkylcarbonyl groups such as phenylpropionyl and benzoylthio lower alkylcarbonyl groups such as 2-(benzoylthio)propionyl. All of these novel 5-fluorouridine derivatives according to the present invention have excellent anti-malignant tumor activity. Examples of the results of examining this anti-malignant tumor effect in CDF 1 mice are shown in Table 3 at the end of this specification. The 5-fluorouridine derivative according to the present invention is
It has an excellent anti-malignant tumor effect, and has an extremely large safety factor (maximum life extension rate dose/25% life extension rate dose), making it excellent in terms of safety. The 5-fluorouridine derivative according to the present invention is N
It can be obtained by bonding the carboxy group of -acyl-α-aminocarboxylic acid and the 5'-OH position of 5-fluorouridine through an ester bonding reaction and esterifying it. The method of this esterification itself is not well specified, either of the well-known esterification methods or their variations. N-acyl-α-aminocarboxylic acid, which is one of the starting materials, is obtained from a suitable acyl halide and α-aminocarboxylic acid that meet the purpose of the present invention according to a conventional method, and can be used in its original form. Alternatively, it can be converted into a reactive derivative such as a halide or anhydride thereof and then subjected to the reaction. In addition, 5-fluorouridine, which is the other starting material, is a known substance, and in order to prevent side reactions, its -OH at the 2' and 3' positions are usually protected with a protecting group by a conventional method. It is best to use this form for the reaction. The protecting group at that time is not specified,
Examples include alkylidene groups such as isopropylidene, ethoxyethylidene, and benzylidene. A preferred reaction method is to form an ester bond between N-acyl-α-aminocarboxylic acid and 2',3'-O-alkylidene-5-fluorouridine, and then remove the alkylidene group to obtain the target compound. In order to form an ester bond between N-acyl-α-aminocarboxylic acid and 2',3'-O-alkylidene-5-fluorouridine by this method, for example, by a conventional method, both are combined in a basic solution in an anhydrous solvent. The compound is reacted with a condensing agent at 40°C or lower in the presence of the condensing agent. In this case, an anhydrous aprotic solvent is used as the solvent, examples of which include benzene, toluene, xylene, halogenated hydrocarbons such as dichloromethane, chloroform, monochloroethane, dichloroethane, trichloroethane, etc., ether,
Examples include tetrahydrofuran, dioxane, pyridine, and nitromethane. As the above basic compound, tertiary amines such as trialkylamine, pyridine, picoline, and lutidine, or inorganic bases such as sodium bicarbonate, sodium carbonate, and barium carbonate can be used, but when pyridine is used, it also serves as a solvent. It has the advantage that it can also be done. As a condensing agent, arylsulfonyl chloride such as p-toluenesulfonyl chloride, triisopropylbenzenesulfonyl chloride, methanesulfonyl chloride, alkylsulfonyl chloride, dicyclohexyl carbodiimide,
Thionyl chloride, phosphorus oxychloride, etc. can be used. The molar ratio of each substance used in the reaction is usually, for example, 1 mole of 2',3'-O-alkylidene-5-fluorouridine to 1 mole each of N-acyl-α-aminocarboxylic acid, basic compound, and condensing agent. ~3 moles. The reaction is carried out at 40°C or lower and is usually completed in 1 to 44 hours. The intermediate produced as a result of this condensation reaction is separated by an appropriate method and the alkylidene group is removed to obtain the desired compound. The reaction to remove the alkylidene group is carried out by a conventional method.
It is carried out in a solvent in the presence of an acid at a temperature below 40°C. Examples of acids used in this case include mineral acids such as hydrochloric acid and sulfuric acid, and organic acids such as acetic acid and trifluoroacetic acid, and examples of solvents include protic solvents such as water, methanol, ethanol, formic acid, acetic acid, etc., or mixtures thereof. can be given. Depending on the case, aprotic solvents may be used in combination. The reaction time is usually 30 minutes to 20 hours. The target compound produced is purified by chromatography or the like. Next, examples related to manufacturing are listed. Example 1 5'-O-(N-benzyloxycarbonylmethionyl)-5-fluorouridine 940 mg (3.3 mmol) of N-benzyloxycarbonyl-L-methionine and 2',3'-O-ethoxyethylidene-5 -Fluorouridine 530mg
(1.7 mmol) was azeotropically dehydrated three times with 5 ml of anhydrous pyridine, then dissolved in anhydrous pyridine, 1.0 g (3.3 mmol) of triisopropylbenzenesulfonyl chloride (hereinafter abbreviated as TPS) was added, and the mixture was heated for 20 minutes at room temperature.
The mixture was stirred for hours to react. The solvent was distilled off under reduced pressure, and the residue was mixed with 100 ml of chloroform and 100 ml of water (this aqueous layer was kept at pH 7.5-8 using solid sodium carbonate).
The chloroform layer was dried over anhydrous sodium sulfate, filtered, and then chloroform was distilled off under reduced pressure. The residue was dissolved in 3 ml of chloroform, adsorbed on 20 g of silica gel, and developed with chloroform containing 1% methanol to give 5'-O-(N-benzyloxycarbonylmethionyl)-2',3'-O-.
Ethoxyethylidene-5-fluorouridine 970
I got mg. [Nuclear magnetic resonance spectrum (DMSO-
d6) δppm11.46 (bs, 1H, H 3 ), 8.08 (d,
1H, H 6 ), 7.30 (s, 5H, phenyl proton),
5.7 (bs, 1H, H 1 '), 5.10 (s, 2H, O-benzylmethylene proton), 3.6 (bq, 2H, C-methylene proton), 2.6 (s, 3H, s-methyl proton), 1.2 ( m, 3H, C-methyl proton)]. Next, dissolve this ester in 15 ml of ethanol, add 3 ml of 90% formic acid aqueous solution and 7 ml of water, and leave at room temperature.
The reaction was allowed to proceed for 20 hours. After the reaction solution was distilled off under reduced pressure, the residue was dissolved in 3 ml of chloroform and silica gel 15
The desired 5'-O-N-benzyloxycarbonylmethionyl-5-fluorouridine was obtained by adsorbing it on 5'-O-N-benzyloxycarbonylmethionyl-5-fluorouridine and developing it with chloroform containing 3% methanol.
790 mg was obtained as a colorless caramel. Mass analysis value: 527 (M + ), 397, 398, 130 Elemental analysis (as C 22 H 26 N 3 O 9 FS) C H N analysis value: 49.85% 5.02% 7.94% Theoretical value: 49.85% 5.02% 7.94% Example 2 5-O-(N-decanoylmethionyl)-5-
Fluorouridine 1.00g (3.30mmol) of 2',3'-O-isopropylidene-5-fluorouridine and 2.00g (6.60mmol) of N-decanoylmethionine were dissolved in 7ml of anhydrous pyridine, followed by 2.00g (6.60mmol) of TPS. was added and allowed to react at room temperature for 44 hours. After evaporating the solvent under reduced pressure, the residue was distributed between 100 ml of chloroform and 100 ml of water (this aqueous layer was kept at pH 7.5 to 8 using solid sodium carbonate), and the chloroform layer was dried over anhydrous sodium sulfate and filtered. Thereafter, chloroform was distilled off under reduced pressure. The residue was dissolved in 5 ml of chloroform, adsorbed on 150 g of silica gel, and developed with chloroform containing 1% methanol.
1.17 g of 5-fluorouridine was obtained as a colorless caramel. [Nuclear magnetic resonance spectrum (CDCl 3 ) δ
ppm, 10.3 (bs, 1H, 3H), 7.70 (d, 0.5H,
H 6 ), 7.60 (d, 0.5H, H 6 ) 5.85 (bs, 0.5H,
H 1 ′), 5.70 (bs, 0.5, H 1 ′), 2.10 (s, 3H, methylthioproton), 1.61, 1.42 (s, s, 3H ×
2, isopropylidene methyl proton), 1.25
(bs, 14H, C-methylene proton), 0.90 (bt,
3H, C-methyl proton)]. Next, add 970 mg (1.65 mmol) of this ester to 90
% trifluoroacetic acid aqueous solution, and stirred and reacted at room temperature for 1 hour. The reaction solution was distilled off under reduced pressure, and the residue was dissolved in 5 ml of chloroform and adsorbed on 20 g of silica gel, and developed with chloroform containing 3% methanol to obtain the desired 5'-O-(N-decanoylmethionyl). )―
750 mg of 5-fluorouridine was obtained. mp133―
6℃ (isopropanol) Mass spectrometry: 547 (M + ), 418, 130, Elemental analysis (as C 24 H 38 N 3 O 8 SF) C H N analysis value: 52.74% 6.85% 7.81% Theoretical value: 52.64% 6.99 % 7.67% Example 3 5'-O-{N-(3-phenylpropionyl)
Methionyl}-5-fluorouridine N-(3-phenylpropion)methionyl
940 mg (3.35 mmol) and 600 mg (1.99 mmol) of 2′,3′-O-isopropylidene-5-fluorouridine
After dissolving in 20ml of anhydrous pyridine, 1.00g of TPS
(3.31 mmol) was added and reacted at room temperature for 4.5 hours.
When this reaction mixture was operated according to Examples 1 and 2, 5'-O-{N-(3-phenylpropionyl)methionyl 2',3'-O-isopropylidene-
350 mg of 5-fluorouridine was obtained as a colorless caramel. [Nuclear magnetic resonance (CDCl 3 ) δppm,
7.54 (d, 0.5H, H 6 ), 7.44 (d, 0.5H, H 6 ),
7.21 (s, 5H, phenyl proton), 5.71 (d,
0.5H, H 1 ′), 5.58 (d, 0.5H, H 1 ′), 2.03 (s,
3H, thiomethyl proton), 1.55, 1.34 (s,
s, 3H×2, isopropylidene methyl proton)]. Add 440 mg (1.20 mmol) of the ester obtained above to
It was dissolved in 2 ml of 90% trifluoroacetic acid aqueous solution and reacted for 1 hour at room temperature. This reaction mixture was prepared in Example 1.
and 2, the desired 5′-O-{N
-(3-phenylpropionyl)methionyl}-
300 mg of 5-fluorouridine was obtained as a colorless caramel. Mass spectrometry: 525 (M + ), 394, 130, Elemental analysis (as C 23 H 28 N 3 O 8 FS) C H N analysis value: 52.64% 5.56% 8.11% Theoretical value: 52.56% 5.37% 8.00% Example 4 5′-O-(N-pentanoylmethionyl)-5
-Fluorouridine N-pentanoylmethionine 3.00g
(12.9 mmol) and 1.94 g (6.44 mmol) of 2',3'-O-isopropylidene-5-fluorouridine were azeotropically dehydrated with anhydrous pyridine, and then
5.50 g (18.2 mmol) of TPS was dissolved in 40 ml and reacted at room temperature for 25 hours. When this reaction mixture was treated according to Examples 1 and 2, 1.39 g of 5'-O-(N-(pentanoylmethionyl)-2',3'-O-isopropylidene-5-fluorouridine) was obtained as colorless caramel. [Nuclear magnetic resonance (CDCl 3 ) δ
ppm, 7.62 (d, 0.5H, H 6 ), 7.42 (d, 0.5H,
H 6 ) 5.77 (bd, 0.5H, H 1 ′), 5.62 (bd, 0.5H,
H 1 ′), 2.07 (s, 3H, thiomethyl proton),
1.56, 1.36 (s, s, 3H x 2, isopropylidene methyl proton), 0.90 (bt, 3H, C-methylene proton)]. Ester obtained above 1.01g (1.95mmol)
was dissolved in 4 ml of chloroform, 20 ml of 90% trifluoroacetic acid aqueous solution was added, and the mixture was reacted at room temperature for 1.5 hours. This reaction mixture was treated according to Examples 1 and 2 to obtain 840 mg of 5'-O-(N-pentanoylmethionyl)-5-fluorouridine as a colorless caramel. Mass spectrometry: 477 (M + ), 347, 130, Elemental analysis (as C 19 H 28 N 3 O 8 SF) C H N analysis value: 47.61% 5.97% 8.52% Theoretical value: 47.79% 5.91% 8.80% Example 5 5'-O-(N-benzyloxycarbonylprolyl)-5-fluorouridine N-benzyloxycarbonyl-L-proline
3.30g (13.2mmol), 2',3'-O-isopropylidene-5-fluorouridine 2.00g (6.6mmol)
Dissolve in 14 ml of anhydrous pyridine, then add 4.00 g of TPS.
(13.2 mmol) was added, and the mixture was stirred and reacted at room temperature for 3 hours. When this reaction mixture was treated according to Examples 1 and 2, 3.00 g of 5'-O-(N-benzyloxycarbonylprolyl)-2',3'-O-isopropylidene-5-fluorouridine was obtained. Ta. [Nuclear magnetic resonance spectrum (CDCl 3 , TMS), δppm,
10.0 (bs, 1H, H 3 ), 7.35 (bs, 6H, phenyl proton and H 6 ), 5.85 (bs, 0.5H, H 1 ′) 5.75
(bs, 0.5H, H 1 ′), 5.20 (s, 2H, benzyl methylene proton), 3.60 (bt, 2H, -N-methylene proton) 2.1 (m, 4H, C-methylene proton), 1.60 (s, 3H, isopropylidene methyl proton), 1.40 (s, 3H, isopropylidene methyl proton)]. Then 3.06g of the ester obtained above
(5.74 mmol) in 12 ml of 90% trifluoroacetic acid aqueous solution
The mixture was stirred and reacted at room temperature for 1.5 hours. This reaction mixture was treated according to Examples 1 and 2.
1.63 g of 5'-O-(N-benzyloxycarbonylprolyl)-5-fluorouridine was obtained. Melting point 137-144° (isopropanol) Mass spectrometry value: 493 (M + ), 358, 130, Elemental analysis (as C 22 H 24 N 3 O 9 F) C H N analysis value: 53.44% 4.89% 8.59% Theoretical value :53.55% 4.90% 8.52% Example 6 5'-O-(N-benzyloxycarbonylvalyl)-5-fluorouridine N-benzyloxycarbonyl-L-valyl
3.51 g (13.98 mmol) and 2',3'-O-isopropylidene-5-fluorouridine 2.72 g
(9.00 mmol) was azeotropically dehydrated with anhydrous pyridine, then dissolved in 50 ml of anhydrous pyridine and TPS5.40 g
(17.82 mmol) was added and reacted at room temperature for 20 hours. When this reaction mixture was treated according to Examples 1 and 2, 5'-O-(N-benzyloxycarbonylvaline)-2',3'-O-isopropylidene-
3.62 g of 5-fluorouridine was obtained as a colorless caramel. [Nuclear magnetic resonance spectrum (CDCl 3 ,
TMS), δppm, 7.40 (s and d, 6H, phenyl proton and H 6 ), 5.63 (d, 1H, H 1 '), 5.18
(s, 2H, benzylmethyl proton), 5.0 (m,
2H, H 2 ′ and H 3 ′), 4.4 (bs, 4H, H 5 ′, H 4 ′ and N-methine proton), 2.2 (m, 1H, C-methine proton), 1.58, 1.46 (s, s , 3H×2, isopropylidene methyl proton), 0.92 (d,
d, 6H, isopropylmethyl proton)]. Next, 3.49 g of the ester obtained above was dissolved in 4 ml of chloroform, 10 ml of a 90% aqueous trifluoroacetic acid solution was added, and the mixture was reacted at room temperature for 3 hours. When this reaction mixture was treated according to Examples 1 and 2,
2.11 g of 5'-O-(N-benzyloxycarbonylvalyl)-5-fluorouridine was obtained as a colorless caramel. Mass analysis value: 495 (M + ), 365, 130 Elemental analysis (as C 22 H 26 N 3 O 9 F・H 2 O) C H N analysis value: 51.56% 5.25% 7.82% Theoretical value: 51.46% 5.50% 8.18% Example 7 5'-O-(N-benzyloxycarbonylphenylalanyl)-5-fluorouridine 3.00 g (10.0 mmol) of N-benzyloxycarbonyl-L-phenylalanine and 2',3'- O-isopropylidene-5-fluorouridine 1.50g
After dissolving (5.00 mmol) in 40 ml of anhydrous pyridine,
3.00 g (10.0 mmol) of TPS was added and stirred at room temperature for 2 hours to react. This reaction mixture was then treated according to the methods of Examples 1 and 2 to provide 5'-O-(N
-benzyloxycarbonylphenylalanyl)
2.80 g of -2',3'-O-isopropylidene-5-fluorouridine was obtained as a colorless caramel.
[Nuclear magnetic resonance spectrum (CDCL 3 , TMS), δ
ppm, 7.39 and 7.3 (s and m, 11H, phenyl proton and H 6 ), 5.68 (d, 1H, H 1 '), 5.15
(s, 2H, O-benzylmethylene proton),
3.15 (d, 2H, C-benzyl proton), 1.58,
1.37 (s, s, 3H x 2, isopropylidene methyl proton)]. 1.20 g of this obtained ester was dissolved in 5 ml of 90% trifluoroacetic acid aqueous solution and stirred at room temperature for 30 minutes to react. This reaction mixture was treated according to Examples 1 and 2 to obtain 940 mg of 5'-O-(N-benzyloxycarbonylphenylalanyl)-5-fluorouridine as a colorless caramel. Mass analysis value: 543 (M + ), 414, 130, Elemental analysis (as C 26 H 26 N 3 O 9 F) C H N analysis value: 57.34% 4.83% 8.00% Theoretical value: 57.46% 4.82% 7.73% Implementation Examples 8 to 16 Corresponding N-acyl-α-aminocarboxylic acids and
The following compound was obtained using 2',3'-O-isopropylidene-5-fluorouridine. 5'-O-(N-phenylacetylmethionyl)
-5-fluorouridine, 5'-O-(N-benzoylglycyl)-5-fluorouridine, 5'-O-(N-decanoylglycyl)-5-fluorouridine, 5'-O-{N -(n-pentanoylglycyl)}-5-fluorouridine, 5'-O-{N-(2-benzoylthiopropionyl)glycyl}-5-fluorouridine, 5'-O-(N-benzyloxycarbonyl -S
-benzylcysteinyl)5-fluorouridine) 5'-O-(N-benzyloxycarbonylglycyl)-5-fluorouridine, 5'-O-(N-benzyloxycarbonyltryptophanyl)-5-fluoro The chemical shift values of the nuclear magnetic resonance spectra of uridine, 5'-O-(N-benzyloxycarbonylseryl)-5-fluorouridine, and each 5-fluorouridine-5'-ester obtained in Examples 1 to 16 are It is shown in Table 1.
【表】【table】
【表】
実施例 17
5′―O―(N―ブチリルバリル)―5―フルオ
ロウリジン
実施例6で得られた5′―O―(N―ベンジルオ
キシカルボニルバリル)―2′,3′―O―イソプロ
ピリデン―5―フルオロウリジン2.20g
(4.11mmol)のイソプロピルアルコール溶液
(93.5ml)に3.7%(wt/wt)塩化水素―イソプロ
ピルアルコール溶液(3.80g)と10%パラジウム
―炭素(1.60g)を加え、水素気流中常温常圧で
3時間撹拌した。反応後、触媒を別し、溶媒を
減圧留去した。残留分として得られた5′―O―バ
リル―2′,3′―O―イソプロピリデン―5―フル
オロウリジン塩酸塩をジクロルメタン(30ml)に
溶かし、2,6―ルチジン0.83g(7.76mmol)
を加えた。この溶液を氷冷し、ブチリルクロリド
0.41g(3.85mmol)のジクロルメタン溶液(10
ml)を滴下した。反応混合物に氷水(25ml)とク
ロロホルム(40ml)を加え、有機層を分取し、2
%―炭酸水素ナトリウム(50ml×2)および水
(50ml×2)にて洗浄した。有機層を乾燥
(Na2SO4)後溶媒を減圧留去し、残留分をシリカ
ゲルカラムクロマトグラフイー(2.54×7.0cm、
クロロホルム―四塩化炭素1:1、クロロホルム
―メタノール99:1)にて分離精製し、5′―O―
(N―ブチリルバリル)―2′,3′―O―イソプロ
ピリデン―5―フルオロウリジン1.00g(54.6
%)を無晶形粉末で得た。
H1―NMR(CDCl3)δppm7.43(1H,d,
H6)6.19(1H,d,アミドプロトン)、5.57
(1H,d,H1′)、1.55(3H,s,イソプロピリデ
ンメチルプロトン)、1.35(3H,s,イソプロピ
リデンメチルプロトン)。
上記で得られた5′―O―(N―ブチリルバリ
ル)―2′,3′―O―イソプロピリデン―5―フル
オロウリジン1.00g(2.12mmol)に90%トリフ
ルオロ酢酸水溶液(20ml)を加え室温で30分間撹
拌した。溶媒を減圧留去し、残留分をシリカゲル
カラムクロマトグラフイー(1.0×20cm、クロロ
ホルム―メタノール97:3)にて分離精製し、
5′―O―(N―ブチリルバリル)―5―フルオロ
ウリジン(無晶形粉末)0.71gを得た。
元素分析(C18H26N3O8Fとして)
C H N
分析値:49.94 6.20 9.36
理論値:50.11 6.07 9.74
実施例 18
5′―O―(N―プロピオニルバリル)―5―フ
ルオロウリジン
実施例17で得られた5′―O―バリル―2′,3′―
O―イソプロピリデン―5―フルオロウリジン塩
酸塩3.57g(8.16mmol)をジクロロメタン(130
ml)に溶かし、2,6―ルチジン1.92g
(17.95mmol)を加える。次いで氷冷撹拌下プロ
ピオニルクロリド0.83g(8.97mmol)のジクロ
ロメタン溶液(20ml)を滴下した。反応液を水
(100ml)で洗浄し、有機層を乾燥(Na2SO4)後、
減圧で濃縮した。残留分をシリカゲルクロマトグ
ラフイ(カラムサイズ3×10cm、展開溶媒1〜4
%のメタノールを含むクロロホルム)により分離
精製し、5′―O―(N―プロピオニルバリル)―
2′,3′―O―イソプロピリデン―5―フルオロウ
リジン2.49g(66.6%)を得た。NMR(CDCl3)
δppm0.90(d)及び0.95(d)(6H、イソプロピルメチ
ルプロトン)、1.18(3H,t,メチルプロト
ン)、1.58(s)及び1.37(s)(6H,イソプロピ
リデンメチルプロトン)、2.30(3H,m,メチン
プロトン、メチレンプロトン)、5.88(1H,d,
H1′)、6.12(1H,d,NH)、7.42(1H,d,C6
―H)、9.30(1H,b,アミドプロトン)
上記で得られたエステル2.00g(4.38mmol)
を90%トリフルオロ酢酸水溶液(10ml)に溶か
し、室温で30分間撹拌した。反応液を減圧で濃縮
し、残分をシリカゲルクロマトグラフイ(カラム
サイズ3×12、展開溶媒1〜4%のメタノールを
含むクロロホルム)により分離精製して、5′―O
―(N―プロピオニルバリル)―5―フルオロウ
リジン1.55gを無晶形粉末として得た。
元素分析(C17H24N3O8Fとして)
C H N
分析値 47.38 5.51 10.42
理論値 48.92 5.79 10.07
実施例 19
5′―O―〔N―チグリルバリル〕―5―フルオ
ロウリジン
実施例17で得られた5′―O―バリル―2′,3′―
O―イソプロピリデン―5―フルオロウリジン塩
酸塩2.20g(5.03mmol)と2,6―ルチジン1.35
g(12.6mmol)をメチレンクロリド(80ml)に
とかし、氷冷下チグリルクロリド0.89g
(7.5mmol)のメチレンクロリド溶液(3ml)を
滴下した。滴下終了後室温で4時間撹拌したの
ち、反応液を2%の炭酸カリウムの水溶液(70
ml)で洗浄し、メチレンクロリド層を乾燥
(Na2SO4)過後、減圧で濃縮した。残分をシリ
カゲルカラムクロマトグラフイー〔φ3×20cm、
展開溶媒クロロホルム―四塩化炭素(1:1)、
クロロホルム、0.5%のメタノールを含むクロロ
ホルム〕により分離精製し、5′―O―(N―チグ
リルバリル)―2′,3′―O―イソプロピリデン―
5―フルオロウリジン1.89gを得た。
NMR(CDCl3)δppm7.55(d,1H,H6)、6.4
(m,2H,ビニルプロトン、アミノプロトン)、
5.70(bs,1H,H1′)、1.84(s,ビニルメチルプ
ロトン)、1.78(d,ビニルメチルプロトン)、
1.55(s)及び1.36(s)(6H,イソプロピリデ
ンメチルプロトン)、0.96(d,6H,イソプロピ
ルメチルプロトン)。
得られたエステル1.65g(3.42mmol)を90%
トリフルオロ酢酸水溶液(10ml)にとかし、室温
で1.5時間撹拌した。反応液を減圧で留去後、残
留分をシリカゲルカラムクロマトグラフイー(φ
3×12cm、展開溶媒クロロホルム、3%のメタノ
ールを含むクロロホルム)により分離精製して
5′―O―〔N―チグリルバリル〕―5―フルオロ
ウリジン1.08gを無色のカラメル状物質として得
た。
元素分析(C19H26N3O8F・0.5H2Oとして)
C H N
分析値 50.13 5.93 9.32
理論値 50.44 6.01 9.29
実施例 20
5′―O―(N―ヘキサノイルバリル)―5―フ
ルオロウリジン
実施例6で得られた、5′―O―(Nベンジルオ
キシカルボニル―バリル)―2′,3′―O―イソプ
ロピリデン―5―フルオロウリジン4.00g
(7.48mmol)のイソプロピルアルコール溶液
(110ml)と3.7%(wt/wt)塩化水素―イソプロ
ピルアルコール溶液(6.90g)と10%パラジウム
―炭素(2.50g)を加え、水素気流中常温常圧で
3時間かくはんした。
触媒を別し溶媒を減圧で留去した。残留分を
ジクロルメタン(60ml)に溶かし、2,6―ルチ
ジン1.70g(15.9mmol)を加えた。この溶液を
氷冷し、ヘキサノイルクロリド1.04g
(7.97mmol)のジクロルメタン溶液(10ml)を滴
下した(30min)。反応液に氷水(100ml)を加
え、クロロホルム(40ml×3)にて抽出した。有
機層を0.5%炭酸カリウム(50ml×4)および水
(50ml×4)で洗浄したのち、乾燥(Na2SO4)し
た。溶媒を減圧留去し、残分をシリカゲルカラム
クロマトグラフイー(2.54×10.0cm、クロロホル
ム―四塩化炭素2:1)にて分離精製し、5′―O
―(N―ヘキサノイル―バリル)―2′,3′―O―
イソプロピリデン―5―フルオロウリジン2.24g
(60%)を得た。
H1―NMR(CDCl3)δppm7.45(1H,d,
H6)、6.32(1H,d,アミドプロトン)、5.60
(1H,bs,H1′)1.54(イソプロピリデンメチル
プロトン)、1.34(イソプロピリデンメチルプロ
トン)。
上記で得られた5′―O―(N―ヘキサノイル―
バリル)―2′,3′―O―イソプロピリデン―5―
フルオロウリジン2.21g(4.42mmol)に90%―
トリフルオロ酢酸水溶液(23ml)を加え、室温で
30分間かくはんした。溶媒を減圧留去し、残留分
をシリカゲルカラムクロマトグラフイー(2.0×
30cm、クロロホルム―メタノール97:3)にて分
離精製し、5′―O―(N―ヘキサノイルバリル―
5―フルオロウリジン1.13gを無晶形粉末として
得た。
元素分析(C20H30N3O8F・0.5H2Oとして)
C H N
分析値 51.67 6.46 9.00
理論値 51.27 6.56 8.96
質量分析値:459(M+)、330、130
実施例 21
5′―O―(N―ペンタノイル―チロシル)―5
―フルオロウリジン
L―チロシン7.00g(38.6mmol)の2N―水酸
化ナトリウム水溶液(38.5ml)にペンタノイルク
ロリド6.0g(50mmol)のエチルエーテル溶液
(50ml)と、2N―水酸化ナトリウム水溶液(26
ml)を5℃でPHを9から11の間に保ちながら、か
くはんし、同時に滴下した(30分)。室温で2時
間さらにかくはんしたのち、反応溶液に2N―水
酸化ナトリウム(5ml)を加え70℃で10分間加温
した。反応液を−10℃に冷却し、ベンジルオキシ
カルボニルクロリド9.87g(58mmol)と2N―水
酸化ナトリウム溶液(20.5ml)とを激しくかくは
んしながら同時に滴下した。反応後、3N―塩酸
を加えてPH3とした。析出した白色沈殿を取
し、クロロホルムから再結晶して、N―ペンタノ
イル―O―ベンジルオキシカルボニル―チロシン
12.80g(82.9%)を得た。
1H―NMR(DMSO―d6)δppm8.06(1H,d,
アミドプロトン)、7.42(5H,s,フエニルプロ
トン)、7.30(d)及び7.11(d)(2H,と2H)、5.26
(2H,s,ベンジルメチレンプロトン)。
上記で得られたO―ベンジルオキシカルボニル
―N―ペンタノイル―チロシン5.30g
(13.3mmol)のピリジン(50ml)溶液にTPS4.0
g(13.2mmol)と2′,3′―O―イソプロピリデン
―5―フルオロウリジン2.10g(6.95g)を加え
室温で16時間放置した。溶媒を減圧留去し、残分
にベンゼン(140ml)を加え、3%炭酸水素ナト
リウム水溶液(100ml×4)および水(100ml×
4)で洗浄した。有機層をNa2SO4で乾燥後、減
圧で濃縮し、残留分をシリカゲルカラムクロマト
グラフイー(2.54×15.0cm;展開溶媒:クロロホ
ルム―四塩化炭素1:1クロロホルム)により分
離精製し、5′―O―(O―ベンジルオキシカルボ
ニル―N―ペンタノイルチロシル2′,3′―O―イ
ソプロピリデン―5―フルオロウリジン1.80g
(37.9%)を得た。
1H―NMR(CDCl3)δppm7.39(s,フエニル
プロトン)、6.36(1H,m,アミドプロトン)、
5.62(1H,d,H1′)、1.51と1.30(イソプロピリ
デンのメチル)。
上記で得られた5―フルオロウリジン―5′―O
―エステル誘導体1.70g(2.49mmol)のイソプ
ロピルアルコール(20ml)溶液に10%パラジウム
―炭素(400mg)を加え、水素気流中常温常圧で
2時間かくはんした。触媒を別し、、溶媒を減
圧留去した。残留分をシリカゲルカラムクロマト
グラフイー(2.54×10.0cm、クロロホルム―メタ
ノール98:2)にて分離精製し、5′―O―(N―
ペンタノイル―チロシニル)―2′,3′―O―イソ
プロピリデン―5―フルオロウリジン1.10g
(80.5%)を得た。
1H―NMR(CDCl3:CD3OD(v/v)5:
1)δppm6.96(2H,d)、6.70(2H,d)、
5.70(1H,d,H1′)、1.55(3H,s,イソプロ
ピリデンメチルプロトン)、1.35(3H,s,イソ
プロピリデンメチルプロトン)。
上記で得られた5′―O―(N―ペンタノイル―
チロシニル)―2′,3′―O―イソプロピリデン―
5―フルオロウリジン1.10g(2.00mmol)に90
%―トリフルオロ酢酸水溶液(12.0ml)を加え、
30分間室温でかくはんした。
溶媒を減圧で留去し、残留分をシリカゲルカラ
ムクロマトグラフイー(2.0×30cm、クロロホル
ム―メタノール96:4)にて分離精製し、5′―O
―(N―ペンタノイル―チロシニル)―5―フル
オロウリジン465mgを無晶形粉末として得た。
元素分析(C23H28N3O9Fとして)
C H N
分析値 53.94 5.49 8.20
理論値 54.22 5.54 8.25
実施例 22〜33
相当するN―アシル―α―アミノカルボン酸と
2′,3′―O―イソプロピリデン―5―フルオロウ
リジンとを用いて以下の化合物を得た。
5′―O―(N―ベンジルオキシカルボニルアラ
ニル)―5―フルオロウリジン
5′―O―(N―ブチリルアラニル)―5―フル
オロウリジン
5′―O―(N―ペンタノイルアラニル)―5―
フルオロウリジン
5′―O―(N―エチルオキシカルボニルバリ
ル)―5―フルオロウリジン
5′―O―(N―アセチルバリル)―5―フルオ
ロウリジン
5′―O―(N―ペンタノイルバリル)―5―フ
ルオロウリジン
5′―O―(N―ベンジルオキシカルボニルイソ
ロイシル)―5―フルオロウリジン
5′―O―(N―ベンジルオキシカルボニルロイ
シル)―5―フルオロウリジン
5′―O―(N―プロピオニルフエニルアラニ
ル)―5―フルオロウリジン
5′―O―(N―ペンタノイルフエニルアラニ
ン)―5―フルオロウリジン
5′―O―(N―プロピオニルチロシル)―5―
フルオロウリジン
5′―O―(N―プロピオニルメチオニル)―5
―フルオロウリジン
実施例17〜33において得られた各―5―フルオ
ロウリジン―5′―エステルの核磁気共鳴スペクト
ルの化学シフト値を表2に示す。[Table] Example 17 5'-O-(N-butyrylvalyl)-5-fluorouridine 5'-O-(N-benzyloxycarbonylvalyl)-2',3'-O- obtained in Example 6 Isopropylidene-5-fluorouridine 2.20g
(4.11 mmol) in isopropyl alcohol solution (93.5 ml), 3.7% (wt/wt) hydrogen chloride-isopropyl alcohol solution (3.80 g) and 10% palladium-carbon (1.60 g) were added, and the mixture was heated at room temperature and pressure in a hydrogen stream. Stirred for 3 hours. After the reaction, the catalyst was separated and the solvent was distilled off under reduced pressure. 5'-O-valyl-2',3'-O-isopropylidene-5-fluorouridine hydrochloride obtained as a residue was dissolved in dichloromethane (30 ml), and 0.83 g (7.76 mmol) of 2,6-lutidine was dissolved.
added. Cool this solution on ice and add butyryl chloride.
A solution of 0.41 g (3.85 mmol) in dichloromethane (10
ml) was added dropwise. Ice water (25 ml) and chloroform (40 ml) were added to the reaction mixture, and the organic layer was separated.
%-sodium hydrogen carbonate (50 ml x 2) and water (50 ml x 2). After drying the organic layer (Na 2 SO 4 ), the solvent was distilled off under reduced pressure, and the residue was subjected to silica gel column chromatography (2.54 x 7.0 cm,
Separation and purification with chloroform-carbon tetrachloride 1:1, chloroform-methanol 99:1) gave 5′-O-
(N-butyrylvalyl)-2',3'-O-isopropylidene-5-fluorouridine 1.00g (54.6
%) was obtained as an amorphous powder. H 1 -NMR (CDCl 3 ) δppm7.43 (1H, d,
H 6 ) 6.19 (1H, d, amide proton), 5.57
(1H, d, H 1 '), 1.55 (3H, s, isopropylidene methyl proton), 1.35 (3H, s, isopropylidene methyl proton). To 1.00 g (2.12 mmol) of 5′-O-(N-butyrylvalyl)-2′,3′-O-isopropylidene-5-fluorouridine obtained above was added 90% trifluoroacetic acid aqueous solution (20 ml) at room temperature. The mixture was stirred for 30 minutes. The solvent was distilled off under reduced pressure, and the residue was separated and purified using silica gel column chromatography (1.0 x 20 cm, chloroform-methanol 97:3).
0.71 g of 5'-O-(N-butyrylvalyl)-5-fluorouridine (amorphous powder) was obtained. Elemental analysis (as C 18 H 26 N 3 O 8 F) C H N analytical value: 49.94 6.20 9.36 Theoretical value: 50.11 6.07 9.74 Example 18 5′-O-(N-propionylbaryl)-5-fluorouridine Example 5′-O-valyl-2′,3′- obtained in 17
3.57 g (8.16 mmol) of O-isopropylidene-5-fluorouridine hydrochloride was dissolved in dichloromethane (130
ml), 1.92 g of 2,6-lutidine
(17.95mmol) is added. Then, a dichloromethane solution (20 ml) containing 0.83 g (8.97 mmol) of propionyl chloride was added dropwise to the mixture under ice-cooling and stirring. After washing the reaction solution with water (100 ml) and drying the organic layer (Na 2 SO 4 ),
Concentrate under reduced pressure. The residue was chromatographed on silica gel (column size 3 x 10 cm, developing solvent 1-4
% methanol in chloroform), and 5'-O-(N-propionylvalyl)-
2.49 g (66.6%) of 2',3'-O-isopropylidene-5-fluorouridine was obtained. NMR ( CDCl3 )
δppm0.90(d) and 0.95(d) (6H, isopropyl methyl proton), 1.18 (3H, t, methyl proton), 1.58 (s) and 1.37 (s) (6H, isopropylidene methyl proton), 2.30 (3H , m, methine proton, methylene proton), 5.88 (1H, d,
H 1 ′), 6.12 (1H, d, NH), 7.42 (1H, d, C 6
-H), 9.30 (1H, b, amide proton) 2.00 g (4.38 mmol) of the ester obtained above
was dissolved in 90% trifluoroacetic acid aqueous solution (10 ml) and stirred at room temperature for 30 minutes. The reaction solution was concentrated under reduced pressure, and the residue was separated and purified by silica gel chromatography (column size 3 x 12, developing solvent chloroform containing 1-4% methanol) to obtain 5'-O
1.55 g of -(N-propionylvalyl)-5-fluorouridine was obtained as an amorphous powder. Elemental analysis (as C 17 H 24 N 3 O 8 F) C H N analysis value 47.38 5.51 10.42 Theoretical value 48.92 5.79 10.07 Example 19 5′-O-[N-Tigrilbaryl]-5-fluorouridine Obtained in Example 17 5′-O-baryl-2′,3′-
O-isopropylidene-5-fluorouridine hydrochloride 2.20 g (5.03 mmol) and 2,6-lutidine 1.35
Dissolve g (12.6 mmol) in methylene chloride (80 ml) and add 0.89 g of tiglyl chloride under ice cooling.
(7.5 mmol) in methylene chloride (3 ml) was added dropwise. After the dropwise addition was completed, the reaction solution was stirred at room temperature for 4 hours, and then added to a 2% aqueous solution of potassium carbonate (70%
ml), and the methylene chloride layer was dried (Na 2 SO 4 ) and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography [φ3×20cm,
Developing solvent chloroform-carbon tetrachloride (1:1),
chloroform, chloroform containing 0.5% methanol] to obtain 5'-O-(N-tigrylbaryl)-2',3'-O-isopropylidene-
1.89 g of 5-fluorouridine was obtained. NMR (CDCl 3 ) δppm7.55 (d, 1H, H 6 ), 6.4
(m, 2H, vinyl proton, amino proton),
5.70 (bs, 1H, H 1 '), 1.84 (s, vinyl methyl proton), 1.78 (d, vinyl methyl proton),
1.55 (s) and 1.36 (s) (6H, isopropylidene methyl proton), 0.96 (d, 6H, isopropyl methyl proton). 90% of the obtained ester 1.65g (3.42mmol)
The mixture was dissolved in an aqueous trifluoroacetic acid solution (10 ml) and stirred at room temperature for 1.5 hours. After distilling off the reaction solution under reduced pressure, the residue was subjected to silica gel column chromatography (φ
3 x 12cm, separated and purified using chloroform (developing solvent, chloroform containing 3% methanol).
1.08 g of 5'-O-[N-thigrivalyl]-5-fluorouridine was obtained as a colorless caramel-like substance. Elemental analysis (as C 19 H 26 N 3 O 8 F・0.5H 2 O) C H N analysis value 50.13 5.93 9.32 Theoretical value 50.44 6.01 9.29 Example 20 5′-O-(N-hexanoylbaryl)-5- Fluorouridine 4.00 g of 5'-O-(N-benzyloxycarbonyl-valyl)-2',3'-O-isopropylidene-5-fluorouridine obtained in Example 6
(7.48 mmol) isopropyl alcohol solution (110 ml), 3.7% (wt/wt) hydrogen chloride-isopropyl alcohol solution (6.90 g), and 10% palladium-carbon (2.50 g) were added. I stirred for hours. The catalyst was separated and the solvent was distilled off under reduced pressure. The residue was dissolved in dichloromethane (60 ml), and 1.70 g (15.9 mmol) of 2,6-lutidine was added. Cool this solution on ice and add 1.04 g of hexanoyl chloride.
(7.97 mmol) in dichloromethane (10 ml) was added dropwise (30 min). Ice water (100 ml) was added to the reaction solution, and the mixture was extracted with chloroform (40 ml x 3). The organic layer was washed with 0.5% potassium carbonate (50 ml x 4) and water (50 ml x 4), and then dried (Na 2 SO 4 ). The solvent was distilled off under reduced pressure, and the residue was separated and purified using silica gel column chromatography (2.54 x 10.0 cm, chloroform-carbon tetrachloride 2:1) to obtain 5'-O
-(N-hexanoyl-valyl)-2',3'-O-
Isopropylidene-5-fluorouridine 2.24g
(60%). H 1 -NMR (CDCl 3 ) δppm7.45 (1H, d,
H 6 ), 6.32 (1H, d, amide proton), 5.60
(1H, bs, H 1 ′) 1.54 (isopropylidene methyl proton), 1.34 (isopropylidene methyl proton). 5′-O-(N-hexanoyl-
Valyl)-2',3'-O-isopropylidene-5-
90% in fluorouridine 2.21g (4.42mmol)
Add trifluoroacetic acid aqueous solution (23 ml) and stir at room temperature.
Stir for 30 minutes. The solvent was distilled off under reduced pressure, and the residue was subjected to silica gel column chromatography (2.0×
30 cm, separated and purified with chloroform-methanol 97:3) to produce 5'-O-(N-hexanoylvalyl-
1.13 g of 5-fluorouridine was obtained as an amorphous powder. Elemental analysis (as C 20 H 30 N 3 O 8 F・0.5H 2 O) C H N analysis value 51.67 6.46 9.00 Theoretical value 51.27 6.56 8.96 Mass analysis value: 459 (M + ), 330, 130 Example 21 5' -O-(N-pentanoyl-tyrosyl)-5
-Fluorouridine A solution of 7.00 g (38.6 mmol) of L-tyrosine in 2N aqueous sodium hydroxide (38.5 ml), an ethyl ether solution (50 ml) of 6.0 g (50 mmol) of pentanoyl chloride, and a 2N aqueous solution of sodium hydroxide (26
ml) was stirred and simultaneously added dropwise (30 minutes) while maintaining the pH between 9 and 11 at 5°C. After further stirring at room temperature for 2 hours, 2N sodium hydroxide (5 ml) was added to the reaction solution and heated at 70°C for 10 minutes. The reaction solution was cooled to -10°C, and 9.87 g (58 mmol) of benzyloxycarbonyl chloride and 2N sodium hydroxide solution (20.5 ml) were added dropwise at the same time with vigorous stirring. After the reaction, 3N-hydrochloric acid was added to adjust the pH to 3. The precipitated white precipitate was collected and recrystallized from chloroform to give N-pentanoyl-O-benzyloxycarbonyl-tyrosine.
12.80g (82.9%) was obtained. 1 H―NMR (DMSO―d 6 ) δppm8.06 (1H, d,
amide proton), 7.42 (5H, s, phenyl proton), 7.30(d) and 7.11(d) (2H, and 2H), 5.26
(2H, s, benzyl methylene proton). 5.30 g of O-benzyloxycarbonyl-N-pentanoyl-tyrosine obtained above
(13.3 mmol) of TPS4.0 in pyridine (50 ml)
g (13.2 mmol) and 2.10 g (6.95 g) of 2',3'-O-isopropylidene-5-fluorouridine were added thereto and left at room temperature for 16 hours. The solvent was distilled off under reduced pressure, benzene (140 ml) was added to the residue, and 3% aqueous sodium hydrogen carbonate solution (100 ml x 4) and water (100 ml x
4). After drying the organic layer with Na 2 SO 4 and concentrating under reduced pressure, the residue was separated and purified by silica gel column chromatography (2.54 x 15.0 cm; developing solvent: chloroform-carbon tetrachloride 1:1 chloroform), and 5' -O-(O-benzyloxycarbonyl-N-pentanoyltyrosyl 2',3'-O-isopropylidene-5-fluorouridine 1.80g
(37.9%). 1H -NMR ( CDCl3 ) δppm7.39 (s, phenyl proton), 6.36 (1H, m, amide proton),
5.62 (1H, d, H 1 '), 1.51 and 1.30 (methyl of isopropylidene). 5-fluorouridine-5′-O obtained above
- To a solution of 1.70 g (2.49 mmol) of the ester derivative in isopropyl alcohol (20 ml) was added 10% palladium-carbon (400 mg), and the mixture was stirred in a hydrogen stream at room temperature and pressure for 2 hours. The catalyst was separated and the solvent was distilled off under reduced pressure. The residue was separated and purified using silica gel column chromatography (2.54 x 10.0 cm, chloroform-methanol 98:2) to obtain 5′-O-(N-
Pentanoyl-tyrosinyl)-2',3'-O-isopropylidene-5-fluorouridine 1.10g
(80.5%). 1 H-NMR (CDCl 3 : CD 3 OD (v/v) 5:
1) δppm6.96 (2H, d), 6.70 (2H, d),
5.70 (1H, d, H 1 '), 1.55 (3H, s, isopropylidene methyl proton), 1.35 (3H, s, isopropylidene methyl proton). 5′-O-(N-pentanoyl-) obtained above
tyrosinyl)-2',3'-O-isopropylidene-
90 in 5-fluorouridine 1.10g (2.00mmol)
%-Trifluoroacetic acid aqueous solution (12.0ml) was added,
Stir for 30 minutes at room temperature. The solvent was distilled off under reduced pressure, and the residue was separated and purified using silica gel column chromatography (2.0 x 30 cm, chloroform-methanol 96:4).
465 mg of -(N-pentanoyl-tyrosinyl)-5-fluorouridine was obtained as an amorphous powder. Elemental analysis (as C 23 H 28 N 3 O 9 F) C H N analytical value 53.94 5.49 8.20 Theoretical value 54.22 5.54 8.25 Examples 22 to 33 Corresponding N-acyl-α-aminocarboxylic acid and
The following compound was obtained using 2',3'-O-isopropylidene-5-fluorouridine. 5'-O-(N-benzyloxycarbonylalanyl)-5-fluorouridine 5'-O-(N-butyrylalanyl)-5-fluorouridine 5'-O-(N-pentanoylalanyl)-5-
Fluorouridine 5'-O-(N-ethyloxycarbonylvalyl)-5-fluorouridine 5'-O-(N-acetylbaryl)-5-fluorouridine 5'-O-(N-pentanoylvalyl)-5 -Fluorouridine 5'-O-(N-benzyloxycarbonylisoleucyl)-5-fluorouridine 5'-O-(N-benzyloxycarbonylleucyl)-5-fluorouridine 5'-O-(N- Propionylphenylalanine)-5-fluorouridine 5'-O-(N-pentanoylphenylalanine)-5-fluorouridine 5'-O-(N-propionyltyrosyl)-5-
Fluorouridine 5'-O-(N-propionylmethionyl)-5
-Fluorouridine Table 2 shows the chemical shift values of the nuclear magnetic resonance spectra of each of the -5-fluorouridine-5'-esters obtained in Examples 17 to 33.
【表】【table】
【表】【table】
Claims (1)
キシ基である) で表わされる5―フルオロウリジン―5′―エステ
ル誘導体。 2 N―アシル―α―アミノカルボン酸と5―フ
ルオロウリジンとをエステル化反応によりエステ
ル結合させることを特徴とする一般式、 (式中、AはN―アシル―α―アミノカルボオ
キシ基である) で表わされる5―フルオロウリジン―5′―エステ
ル誘導体の製造法。[Claims] 1. General formula (In the formula, A is an N-acyl-α-aminocarboxy group.) A 5-fluorouridine-5'-ester derivative represented by: 2 A general formula characterized by forming an ester bond between N-acyl-α-aminocarboxylic acid and 5-fluorouridine through an esterification reaction, (In the formula, A is an N-acyl-α-aminocarboxy group.) A method for producing a 5-fluorouridine-5'-ester derivative represented by the following formula.
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15292279A JPS5677298A (en) | 1979-11-28 | 1979-11-28 | Movel 5-fluorouridine derivative and its preparation |
US06/210,796 US4340728A (en) | 1979-11-28 | 1980-11-26 | Nucleoside derivatives and process for preparing same |
IT26289/80A IT1141100B (en) | 1979-11-28 | 1980-11-27 | NUCLEOSIDIC DERIVATIVES AND PROCESS FOR THEIR PREPARATION |
DE19803044740 DE3044740A1 (en) | 1979-11-28 | 1980-11-27 | NUCLEOSIDE DERIVATIVES, THEIR PRODUCTION AND PHARMACEUTICAL AGENTS |
FR8025348A FR2470774A1 (en) | 1979-11-28 | 1980-11-28 | NUCLEOSIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USES |
GB8038211A GB2066812B (en) | 1979-11-28 | 1980-11-28 | 5'-acyl-uridine derivatives and processes for the preparation thereof |
CH883380A CH646441A5 (en) | 1979-11-28 | 1980-11-28 | NUCLEOSIDE DERIVATIVES, THEIR PRODUCTION AND THE PHARMACEUTICAL PRODUCTS CONTAINING THEM. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15292279A JPS5677298A (en) | 1979-11-28 | 1979-11-28 | Movel 5-fluorouridine derivative and its preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5677298A JPS5677298A (en) | 1981-06-25 |
JPS621399B2 true JPS621399B2 (en) | 1987-01-13 |
Family
ID=15551073
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP15292279A Granted JPS5677298A (en) | 1979-11-28 | 1979-11-28 | Movel 5-fluorouridine derivative and its preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5677298A (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61134397A (en) * | 1984-12-01 | 1986-06-21 | Fuji Kagaku Kogyo Kk | 5'-o-oligopeptidyl-5-fluorouridine and production thereof |
JPS61246196A (en) * | 1985-04-22 | 1986-11-01 | Fuji Kagaku Kogyo Kk | 5'-o-acyl-5-fluorouridine and production thereof |
EP0268678B1 (en) * | 1986-05-30 | 1992-07-29 | Fuji Kagaku Kogyo Kabushiki Kaisha | Novel 5-fluorouridine compounds and process for their preparation |
-
1979
- 1979-11-28 JP JP15292279A patent/JPS5677298A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS5677298A (en) | 1981-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5606048A (en) | Stereoselective glycosylation process for preparing 2'-Deoxy-2', 2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides | |
US5401838A (en) | Stereoselective fusion glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides | |
CA2105112C (en) | A process for anomerizing nucleosides | |
JPH069602A (en) | Intermediate of difluoro antiviral agent | |
WO2007009303A1 (en) | Process for synthesizing n4-acyl-5'-deoxy-5-fluorocytidine derivatives | |
JPH06157570A (en) | Stereoselective glycosylation | |
IL105810A (en) | Erythromycin derivatives and pharmaceutical compositions comprising them | |
JPS6247196B2 (en) | ||
KR970002659B1 (en) | PROCESS AND INTERMEDIATES OF 2óÑ,2óÑ-DIFLUORONUCLEOSIDES | |
PT89392A (en) | PROCESS FOR THE PREPARATION OF ADENOSIN DERIVATIVES | |
JPH0371440B2 (en) | ||
JP2002538144A (en) | Antiviral 2,4-pyrimidinedione derivative and method for producing the same | |
ES2208540T3 (en) | PROCEDURE FOR THE PREPARATION OF RIBAVIRINE. | |
JPS621399B2 (en) | ||
WO2009094847A1 (en) | A capecitabine hydroxyl-derivative, its preparation processes and uses for preparing capecitabine | |
JP3659989B2 (en) | Stereoselective preparation of 2-deoxy-2,2-difluoro-D-ribofuranosyl-3,5-hydroxy protected-1-alkyl and aryl sulfonate intermediates rich in β-anomer | |
JP3029806B2 (en) | Glycosidation of colchicine derivative and product thereof | |
JP2735609B2 (en) | UCN-1028D derivative | |
JP2744454B2 (en) | Method for producing beta-2 ', 2'-difluoronucleosides | |
US4140850A (en) | 2,2'-Anhydrotriazine nucleosides and process for preparing the same | |
Matulic-Adamic et al. | Synthesis of 1-deoxy-1-C-(p-Aniline)-β-D-ribofuranose and its incorporation into hammerhead ribozymes | |
US20030236397A1 (en) | Process for preparing beta-L-2'deoxy-thymidine | |
PL143289B1 (en) | Process for preparing 5-/e/-/2-bromovinyl/-2'-desoxyuridine and its novel derivatives | |
WO1998032736A1 (en) | Process for producing benzylsuccinic acid derivatives | |
US8168766B2 (en) | Process of making 2-deoxy-2,2-difluoro-D-ribofuranosyl nucleosides and intermediates therefor |